Innovative Approaches for Next-Generation Drug Delivery and Personalized Healthcare

Abstract

In recent years, 3D printing in the pharmaceutical sector has grown dramatically. Hybrid 3D Printing (H3DP) is increasingly used because it prints structures with different qualities from multiple materials. This technology allows polymers, metals, ceramics, and even active pharmaceutical ingredients to be used in additive manufacturing processes to create complex geometries, porous structures, and high-resolution parts. H3DP is important for pharmaceutical manufacturing because it enables the development of innovative drug delivery systems with desirable morphologies, biodegradability, drug loading, and drug release characteristics by mixing multiple materials. Due to H3DP technologies, pharmaceutical companies are experiencing a growing demand for customized conventional dosage forms, drug-eluting and drug-loaded devices that target infection zones, and personalized medical devices. H3DP methods such as photopolymerization, powder bed fusion, and extrusion use polymers, metals, and ceramics to improve medication delivery, precision, and cost. The H3DP approach has the potential to transform the pharmaceutical industry with innovative drug delivery systems and personalized treatment options customized to patients' needs.